Alternative in Beta Blocker Intolerance: The ABBI Trial

NCT00893984 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Lack of patient recruitment

Conditions

Coronary Artery Disease

Interventions

DRUG: Nebivolol

Sponsor

Minneapolis Heart Institute Foundation

Collaborators

[object Object]